Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
Arrhythmogenic right ventricular dysplasia (ARVD), also known as arrhythmogenic right ventricular cardiomyopathy (ARVC), is a leading cause of sudden death among young athletes. But it can affect people of all ages and all activity levels.
At the Johns Hopkins Arrhythmogenic Right Ventricular Dysplasia (Cardiomyopathy) Program, we are committed to finding a cure for ARVD (ARVC). We help patients and their families with screening, education and advanced medical and surgical treatments.